Celestial Biolabs (Delisted) results

BSE: 532871Pharmaceuticals & Biotechnology

Formerly Celestial Labs

Last traded ₹1.75 on 11 Mar 2020

Delisted on 16 Oct 2024.

Q3 results, quarter to Dec 2023

Standalone: the listed company alone, without its subsidiaries. ₹ crore.Celestial Biolabs annual results and balance sheet

Revenue
₹0.04 Cr+8.9% on a year ago · +2.8% on the quarter before
Operating profit
−₹0.03 Cr
Net profit
−₹0.03 Cr
Earnings per share
−₹0.02
Operating margin
−76.9%
Net margin
−93.5%

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Materials and goods0.0
  3. Employee costs0.0
  4. Other expenses0.0
  5. Operating profit0.0
  6. Depreciation0.0
  7. Other income0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

Celestial Biolabs results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2023. Results for the quarter to Mar 2024 were due by 30 May 2024, 60 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreMar 2019Q4Filed 14 JunJun 2019Q1Filed 17 AugSep 2019Q2Filed 9 SepDec 2019Q3Filed 9 SepMar 2020Q4Filed 9 SepJun 2020Q1Filed 9 SepSep 2020Q2Filed 9 SepDec 2020Q3Filed 9 SepMar 2021Q4Filed 9 SepJun 2021Q1Filed 9 SepSep 2021Q2Filed 9 SepDec 2021Q3Filed 9 SepMar 2022Jun 2022Filed 28 NovSep 2022Filed 25 NovDec 2022Q3Filed 17 FebMar 2023Q4Filed 4 AprJun 2023Q1Filed 4 AprSep 2023Q2Filed 4 AprDec 2023Q3Filed 4 Apr
Revenue from operations3.04.30.70.30.00.00.00.00.00.00.00.0–0.10.00.00.00.00.00.0
−0.82.997.90.30.20.10.00.00.10.00.10.1–0.10.10.20.30.10.10.1
Materials and goods bought−2.52.50.50.20.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Employee costs0.20.20.00.00.00.00.00.00.00.00.00.0–0.00.00.10.10.00.00.0
Other expenses1.50.297.40.00.20.10.00.00.10.00.00.0–0.10.00.10.20.10.00.0
Operating profit before depreciation3.81.4−97.30.0−0.2−0.10.00.0−0.10.00.00.0–−0.1−0.1−0.1−0.2−0.10.00.0
Operating margin127.2%31.6%−14,626.8%−3.6%––––––−47.9%−111.3%–−169.9%−177.5%−429.0%−602.9%−411.1%−74.9%−76.9%
Depreciation and amortisation3.72.20.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Other income0.30.00.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Finance costs1.00.10.40.40.40.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
One-off items0.00.00.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Profit before tax−0.5−1.0−97.7−0.5−0.6−0.10.00.0−0.1−0.10.00.0–−0.1−0.1−0.2−0.2−0.10.00.0
Tax0.00.00.00.0−1.40.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Net profit−0.5−1.0−97.7−0.50.8−0.10.00.0−0.1−0.10.00.0–−0.1−0.1−0.2−0.2−0.10.00.0
Net margin−18.1%−23.4%−14,693.4%−154.7%––––––−64.1%−131.2%–−184.0%−195.9%−451.8%−622.4%−436.7%−91.1%−93.5%
Earnings per share−₹0.24−₹0.44−₹43.26−₹0.20₹0.36−₹0.03−₹0.01−₹0.01−₹0.03−₹0.02−₹0.01−₹0.02–−₹0.04−₹0.04−₹0.07−₹0.10−₹0.04−₹0.01−₹0.02
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2022.

Filed results, as an XML file each

15 earlier filings